Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis
Grypiotis, P.; Cozzi, F.; Ruffatti, A.
Journal of Rheumatology 31(7): 1468-1469
2004
ISSN/ISBN: 0315-162X PMID: 15229985 Document Number: 581943
Document emailed within 1 workday
Related Documents
Esquivel-Valerio, J.A.; Flores-Suárez, L.F.; Rodríguez-Amado, J.; Garza-Elizondo, M.A.; Rendón, A.án.; Salinas-Carmona, M.C. 2010: Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation Clinical and Experimental Rheumatology 28(1 Suppl 57: 35-39Schindler, R.; Marra, M.N.; McKelligon, B.M.; Lonnemann, G.; Schulzeck, P.; Schulze, M.; Oppermann, M.; Shaldon, S. 1993: Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis Clinical Nephrology 40(6): 346-351
Weersink, A.J.; van Kessel, K.P.; van den Tol, M.E.; van Strijp, J.A.; Torensma, R.; Verhoef, J.; Elsbach, P.; Weiss, J. 1993: Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein Journal of Immunology 150(1): 253-263
Punzi, L.; Peuravuori, H.; Jokilammi-Siltanen, A.; Bertazzolo, N.; Nevalainen, T.J. 2000: Bactericidal/permeability increasing protein and proinflammatory cytokines in synovial fluid of psoriatic arthritis Clinical and Experimental Rheumatology 18(5): 613-615
Nell, M.J.; Albers-Op 't Hof, B.M.; Koerten, H.K.; Grote, J.J. 2000: Inhibition of endotoxin effects on cultured human middle ear epithelium by bactericidal permeability-increasing protein American Journal of Otology 21(5): 625-630
Yeh, T.M.; Chao, S.C.; Chang, H.C. 1994: Lipopolysaccharide binding and antibacterial activities of a synthetic peptide representing amino acids 90-101 of bactericidal/permeability-increasing protein Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 27(3): 120-132
Levy, O.; Ooi, C.E.; Elsbach, P.; Doerfler, M.E.; Lehrer, R.I.; Weiss, J. 1995: Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins Journal of Immunology 154(10): 5403-5410
Capodici, C.; Weiss, J. 1996: Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function Journal of Immunology 156(12): 4789-4796
Leibe, S.; Wagner, J. 1976: Permeability-increasing effect of punctates. 3. Inhibition of the permeability-increasing activity by contrykal Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(6): 172-175
Greenbaum, E.; Laufer, M.; Shoenfeld, J. 1993: Autoantibodies in systemic sclerosis (scleroderma) Harefuah 124(6): 370-374
Derk, C.T.; Sakkas, L.I.; Rasheed, M.; Artlett, C.; Jimenez, S.A. 2003: Autoantibodies in patients with systemic sclerosis and cancer: a case-control study Journal of Rheumatology 30(9): 1994-1996
Oĭvin, I.A.; Gaponiuk, P.I.; Oĭvin, V.I.; Tokarev, O.I.; Volodin, V.M. 1972: Mechanisms involved in increasing the vascular permeability under the effect of permeability factors (histamine, serotonin, Bradykinin and inflammatory agents Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 16(4): 19-23
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548
Lesavre, P.; Nusbaum, P.; Halbwachs-Mecarelli, L. 1993: Methods of detection of anti-cathepsin G autoantibodies in human Advances in Experimental Medicine and Biology 336: 257-261
Hirano, T.; Yoshioka, H. 1993: Serum cathepsin B levels, urinary excretion of cathepsin B and tissue cathepsin B content in the patients with gastric cancer Nihon Geka Hokan. Archiv für Japanische Chirurgie 62(5): 217-221
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Gawrysiak, W.; Skrypnik, K.; Suliburska, J.; Skrypnik, D.; Bogdański, Pł. 2017: Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis Przeglad Lekarski 74(4): 179-182
Obata, T.; Takahashi, H.; Nosho, K.; Ikeda, Y.; Tokuno, T.; Kawahito, Y.; Honda, S.; Makiguchi, Y.; Imai, K.; Ikeda, T. 1998: A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach Ryumachi 38(6): 810-817
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Butov, I.S. 1980: Antinuclear autoantibodies in systemic diseases Vestnik Dermatologii i Venerologii 11: 17-22